J. B. Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM.NS

1886.5 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q12016 Q42015 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 955.4-3,932.9916.2-2,692.038769.3-1,968.2846.8-566.503565.441-7,673.063353.447-6,936.603286.855-4,954.527343.694-3,664.357290.079-5,735.781338.906-3,970.264353.968-4,125.531133.864149.567
Short Term Investments 3,646.57,865.83,544.45,384.0762,159.33,936.41,439.71,133.0061.06215,346.1267,367.39413,873.2066,649.7489,909.0544,610.8337,328.7143,338.12611,471.5625,396.8757,940.5283,606.4998,251.0622,261.0211,952.497
Cash and Short Term Investments 4,601.93,932.94,460.62,692.0382,928.61,968.22,286.5566.503566.5037,673.0637,720.8416,936.6036,936.6034,954.5274,954.5273,664.3573,628.2055,735.7815,735.7813,970.2643,960.4674,125.5312,394.8852,102.064
Net Receivables 6,876.207,159.605,771.706,691.406,238.84404,953.83404,186.72504,215.51603,454.26203,429.04404,068.36902,668.9230
Inventory 5,025.104,245.304,304.904,445.404,099.61103,630.61403,474.46803,776.21602,746.69702,420.16302,437.57602,001.6861,879.833
Other Current Assets 2,030.301,71402,275.101,984.901,843.5920887.3310928.2280711.52404,352.3820601.691029.3410883.4083,795.669
Total Current Assets 18,533.53,932.917,579.52,692.03815,280.31,968.215,408.2566.50312,748.557,673.06317,192.626,936.60315,526.0244,954.52713,657.7833,664.35710,727.2845,735.78112,186.6793,970.26410,495.7534,125.5317,948.9027,777.566
Non-Current Assets:
Property, Plant & Equipment, Net 6,348.806,370.205,764.205,593.605,668.15905,753.71705,696.5505,773.27505,841.96605,820.18605,595.06606,010.3285,018.973
Goodwill 574.60574.60574.60574.60574.5920574.5920574.5920574.5920531.40531.40531.4000
Intangible Assets 13,884.6012,951.8013,222.8010,115.306,713.9440323.9910321.0520305.8680300.9240228.5310233.775000
Goodwill and Intangible Assets 14,459.2013,526.4013,797.4010,689.907,288.5360898.5830895.6440880.460832.3240759.9310765.1750821.739693.721
Long Term Investments 342.60-3,298.40137.8410127.20127.2210183.9330-6,518.8080-4,480.4060-2,642.2580-4,722.1690-2,646.1610-337.724-104.185
Tax Assets 58.8054065.1082.8064.31070.189069.4304,643.58303,376.29405,433.7230002,264.064-693.721
Other Non-Current Assets 198.4-3,932.93,760.3-2,692.038493.859-1,968.2165.3-566.503177.246-7,673.06369.772-6,936.6036,712.312-4,954.52761.737-3,664.3570.001-5,735.78179.875-3,970.2643,700.172-4,125.53133.0772,881.487
Total Non-Current Assets 21,407.8-3,932.920,412.5-2,692.03820,258.4-1,968.216,658.8-566.50313,325.472-7,673.0636,976.194-6,936.6036,855.128-4,954.5276,878.649-3,664.3577,408.327-5,735.7817,371.546-3,970.2647,414.252-4,125.5318,791.4847,796.275
Total Assets 39,941.3037,992035,538.7032,067026,074.022024,168.814022,381.152020,536.432018,135.611019,558.225017,910.005016,740.38615,573.841
Liabilities & Equity:
Current Liabilities:
Account Payables 3,563.103,224.102,386.402,540.202,244.79701,906.00501,869.23401,451.22301,237.92501,074.2730827.6060989.77111.617
Short Term Debt 3,443.801,580.701,739.101,253.20339.4120327.0420398.4650305.6990369.8910471.1390257.9770488.6031,930.237
Tax Payables 117.60195.7049.5062.4060.945060.339079.0190170.012000144.23039.36608.7390
Deferred Revenue 117.601,439.101,182.501,516.101,164.7460922.477079.01901,346.5901,504.15801,371.66401,339.64201,249.8661,067.884
Other Current Liabilities 1,557.80183.30236.50252.9088.2010114.59701,106.0190353.537016.4860187.56707.132083.8441,348.257
Total Current Liabilities 8,682.306,427.205,544.505,562.403,837.15603,270.12103,452.73703,457.04903,128.4603,104.64302,432.35702,812.0844,357.995
Non-Current Liabilities:
Long Term Debt 236.402,92303,985.402,493.30206.1760227.639051.414070.542012.29200035.26000
Deferred Revenue Non-Current 96.401780152.10148.8031.6640204.403049.3220-70.542059.68400022.029000
Deferred Tax Liabilities Non-Current 1,49201,27401,028.206860475.5910591.3230567.6660470.7510481.4040483.7520569.0730104.639158.24
Other Non-Current Liabilities 200.9022.7025023.40137.306040.9150125.7140320.148073.8680103.54022.0290165.361104.329
Total Non-Current Liabilities 2,025.704,397.705,190.703,351.50850.73701,064.280794.1160790.8990627.2480587.2920648.3910270262.569
Total Liabilities 10,708010,824.9010,735.208,913.904,687.89304,334.40104,246.85304,247.94803,755.70803,691.93503,080.74803,082.0844,620.564
Equity:
Preferred Stock 000000000000000000000000
Common Stock 155.201550154.80154.70154.5640154.5640154.5640154.5640154.5640160.4730160.4730169.64169.64
Retained Earnings 25,132.98900022,757.07100018,427.06900015,847.93500012,329.46700011,024.32005,405.686
Accumulated Other Comprehensive Income/Loss 29,078.127,167.127,012.124,803.5222,698.76123,153.122,998.421,341.232,248.42919,795.06119,640.49718,097.248662.24616,259.78416,105.2214,354.893-5,154.10215,837.28315,676.8114,801.224-4,534.45714,415.580-3,058.092
Other Total Stockholders Equity -25,132.989000-807.1320044.899511.16839.352037.0511,432.50328.7025.017,024.96429.007028.0338,150.88827.71813,466.8578,420.083
Total Shareholders Equity 29,233.327,167.127,167.124,803.52224,803.523,153.123,153.121,386.12921,341.2319,834.41319,795.06118,134.29918,097.24816,288.48416,259.78414,379.90314,354.89315,866.2915,837.28314,829.25714,801.22414,443.29813,636.49710,937.317
Total Equity 29,233.327,167.127,167.124,803.52224,803.523,153.123,153.121,386.12921,386.12919,834.41319,834.41318,134.29918,134.29916,288.48416,288.48414,379.90314,379.90315,866.2915,866.2914,829.25714,829.25714,443.29813,658.30210,953.277
Total Liabilities & Shareholders Equity 39,941.327,167.137,99224,803.52235,538.723,153.132,06721,386.12926,074.02219,834.41324,168.81418,134.29922,381.15216,288.48420,536.43214,379.90318,135.61115,866.2919,558.22514,829.25717,910.00514,443.29816,740.38615,573.841